Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 23 a rand..
本文档由 louguangdan1996 分享于2015-11-28 02:25
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 23 a randomised, double-blind, placebo-controlled phase 2b trial
君，已阅读到文档的结尾了呢~~